57 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Jun 24
Report of Foreign Private Issuer
8:05am
and anti-inflammatory medication to reduce pain and swelling start losing their effectiveness. Currently, there are no effective long-term treatments
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and other liabilities (note 8)
Liability classified as held for sale (note 16)
Total Current Liabilities
Non-Current Liabilities
Other long-term Liabilities … term, revenues. There are no assurances, however, that the Company will be successful in obtaining the financing necessary for its long-term development
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
Current Liabilities
Accounts payable
Accrued expenses and other liabilities
Total Current Liabilities
Non-Current Liabilities
Other long-term liabilities … term, revenues. There are no assurances, however, that the Company will be successful in obtaining the financing necessary for its long-term development
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
and long-term lease liabilities, as applicable.
Operating lease liabilities and their corresponding right-of-use assets are initially recorded based
6-K
EX-99.1
hym06
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
6z2hl6if
11 Sep 23
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
8:00am
6-K
EX-99.1
4mycmvhitv n0
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
4dk0tyu lxrgahietf
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
1199qvm kronf
26 Jun 23
Enlivex Announces First Quarter 2023 Financial Results and Provides a Business Update
8:03am
6-K
EX-99.1
uhr 4rzeo2
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
y991 lky1ltj6
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
mchu nyabwc
31 Mar 23
Report of Foreign Private Issuer
4:30pm
424B5
r61s3gdn1xi2ai0imv
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
uh63xaj964f0tr
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
jpyggsf
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
gfn9xxyzov1fj5cp
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
ptuu5e
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
tnolttz ksl
22 Aug 22
Condensed Consolidated Financial Statements
8:08am